Cleared Traditional

K132930 - MYHEALTHPOINT TELEHEALTH MANAGER

K132930 is an FDA 510(k) clearance for MYHEALTHPOINT TELEHEALTH MANAGER, manufactured by Entra Health Systems. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 208-day FDA review.

K132930 · Entra Health Systems · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2014
Decision
208d
Days
Class 2
Risk

K132930 is an FDA 510(k) clearance for the MYHEALTHPOINT TELEHEALTH MANAGER. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Entra Health Systems (San Diego, US). The FDA issued a Cleared decision on April 14, 2014 after a review of 208 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Entra Health Systems devices

FDA 510(k) Submission Details - K132930

510(k) Number K132930 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 18, 2013
Decision Date April 14, 2014
Days to Decision 208 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d slower than avg
Panel avg: 125d · This submission: 208d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 134
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K132930.
ECARE COORDINATOR (ECC)
K141706 · Visicu, Inc. · Sep 2014
VITALCONNECT PLATFORM (CONSISTING OF VITALCONNECT SENSOR, RELAY SOFTWARE LIBRARY AND SECURE SERVER SOFTWARE LIBRARY)
K141167 · Vitalconnect, Inc. · Jul 2014
FAMILY HEALTHWARE
K132173 · Sanitas, Inc. · May 2014
VITALCONNECT PLATFORM BY VITAL CONNECT INC.
K132447 · Vitalconnect, Inc. · Apr 2014
HEALTHINTERLINK BEACON
K133252 · Healthinterlink, LLC · Mar 2014
VERIZON WIRELESS CONVERGED HEALTH MANAGEMENT DEVICE
K134004 · Cellco Partnership D/B/A Verizon Wireless · Feb 2014